رجوع
نطاق اليوم
KWD 5.31
KWD 5.80
نطاق 52 أسبوعًا
KWD 2.25
KWD 8.90
حجم التداول
2,034,363
متوسط 50 يوم / 200 يوم
KWD 6.89
/
KWD 5.61
الإغلاق السابق
KWD 5.22
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -1.9 | 0.2 |
| P/B | — | 3.0 |
| ROE % | -565.3 | 3.6 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 9.7 |
| D/E | — | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 18.00
+220.3%
Low: KWD 15.00
High: KWD 22.00
ربحية السهم المستقبلية
-KWD 1.79
الإيرادات المقدّرة
560,000.0
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 0.81
KWD 0.81 – KWD 0.81
|
535.60M | 2 |
| FY2028 |
-KWD 0.83
-KWD 0.83 – -KWD 0.83
|
245.36M | 3 |
| FY2027 |
-KWD 1.63
-KWD 1.63 – -KWD 1.63
|
43.00M | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-24 | -KWD 0.43 | -KWD 0.59 | -37.1% |
| 2025-11-04 | -KWD 0.40 | -KWD 0.38 | +5.0% |
| 2025-07-31 | -KWD 0.37 | -KWD 0.38 | -2.7% |
| 2025-05-08 | -KWD 0.47 | -KWD 0.44 | +6.4% |
| 2025-02-27 | -KWD 0.62 | -KWD 0.63 | -1.6% |
| 2024-10-31 | -KWD 0.60 | -KWD 0.56 | +6.7% |
| 2024-08-01 | -KWD 0.53 | -KWD 0.56 | -5.7% |
| 2024-05-08 | -KWD 0.52 | -KWD 0.55 | -5.8% |
Insider Trading Activity
14 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 |
Nath Kabir
Chief Executive Officer
|
other | 13,131 | KWD 6.89 | KWD 90,472.59 |
| Mar 11, 2026 |
Loxam Teri
Chief Financial Officer
|
other | 1,781 | KWD 6.89 | KWD 12,271.09 |
| Mar 2, 2026 |
Loxam Teri
Chief Financial Officer
|
other | 4,467 | KWD 7.02 | KWD 31,358.34 |
| Feb 2, 2026 |
Nath Kabir
Chief Executive Officer
|
other | 16,181 | KWD 6.61 | KWD 106,956.41 |
| Oct 29, 2025 |
JONAS JEFFREY M
Director
|
grant | 52,000 | — | — |
| Aug 1, 2025 |
Nath Kabir
Chief Executive Officer
|
other | 6,366 | KWD 4.34 | KWD 27,628.44 |
| Jul 29, 2025 |
Gover Justin D.
Director
|
grant | 52,000 | — | — |
| Jun 12, 2025 |
McQuade Robert
Director
|
grant | 26,000 | — | — |
| Jun 12, 2025 |
SANTINI GINO
Director
|
grant | 39,000 | — | — |
| Jun 12, 2025 |
Jenkins Annalisa
Director
|
grant | 26,000 | — | — |
| Jun 12, 2025 |
Karydas Daphne
Director
|
grant | 26,000 | — | — |
| Jun 12, 2025 |
Norton David Y
Director
|
grant | 26,000 | — | — |
| Jun 12, 2025 |
Lonngren Thomas
Director
|
grant | 26,000 | — | — |
| Jun 12, 2025 |
McGoldrick Linda
Director
|
grant | 26,000 | — | — |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Negative free cash flow of -157.24M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-565.28%
ROICN/A
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
N/A
Current Ratio0.77
Interest Coverage39.64
التقييم
P/E Ratio
-1.88
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -287.86M |
| ROE | -565.28% | ROA | -136.85% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -157.24M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.77 |
| Interest Coverage | 39.64 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.88 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | -0.07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 964.29 | Fwd Earnings Yield | N/A |
| FCF Yield | -29.12% | ||
| Market Cap | 540.00M | Enterprise Value | 411.32M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -287.86M | -155.12M | -118.46M | -91.51M | -71.74M |
| EPS (Diluted) | -3.08 | -2.30 | -2.32 | -2.16 | -1.79 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -179.04M | -178.21M | -136.92M | -110.40M | -83.22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 210.35M | 213.67M | 275.99M | 197.29M | 300.90M |
| Total Liabilities | 263.20M | 58.97M | 50.24M | 16.01M | 16.49M |
| Shareholders' Equity | -52.85M | 154.70M | 225.74M | 181.28M | 284.41M |
| Total Debt | 20.93M | 32.19M | 33.05M | 1.93M | 3.61M |
| Cash & Equivalents | 149.61M | 165.08M | 220.20M | 143.21M | 273.24M |
| Current Assets | 191.49M | 201.29M | 261.30M | 191.65M | 295.30M |
| Current Liabilities | 247.80M | 34.02M | 19.60M | 15.60M | 15.11M |